The Study of Different Sedative Medications in Monitored Anesthesia Care During Eye Surgery With Local Anesthesia
MAC
Effective Dose of Dexmedetomidine or Midazolam in Monitored Anesthesia Care for Patients Undergoing Ophthalmologic Surgery With Retrobulbar Nerve Block
1 other identifier
interventional
150
1 country
1
Brief Summary
Due to the delicacy and long duration of the procedure, ophthalmic surgery put forward higher requirements to anesthesia management:
- 1.The patient with local anesthesia without sedation is in a state of awareness, which will cause intense stress resulting in increased blood pressure, heart rate, muscle tension and even sense of pain;
- 2.Traction of extraocular muscles and eyeballs can induce oculocardiac reflex, followed by bradycardia, atrial or ventricular arrhythmia, conduction block, and even more worsen, life-threatening cardiac arrest may occur;
- 3.With the increase in average life expectancy and the improvement of quality of life requirements, the number of elderly patients in ophthalmic surgery is also increasing. These elderly patients are often combined with hypertension, diabetes, etc. and decreased tolerance of with general anesthesia;
- 4.For some retinal detachment surgery with difficulty in resetting, the patients will be required to change to the prone position immediately after surgery to improve the success rate of resetting. Conventional general anesthesia management are cumbersome and costly, which may not be likely to achieve the swift emergence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2019
CompletedFirst Posted
Study publicly available on registry
July 12, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedNovember 3, 2020
November 1, 2020
1.7 years
July 9, 2019
November 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Perioperative change of Observer's Assessment of Alertness/Sedation scale (OAA/S)
Conventional subjective sedation scales with 1 to 5. Successful sedation was defined as an OAA/S scale score between 1 and 3, while failure was defined as an OAA/S score of more than 3.
OAA/S score will be recorded from patient arrival in the operating room to about 30 minutes after surgery at following time points: before sedative administration, before skin incision, every 5 minutes intraoperatively and every 10 minutes in PACU.
Numerical rating scale (NRS)
The surgeons rated anesthesia management on a numerical rating scale (NRS), ranging from 0 to 10, with 10 defined as the best condition and 0 as the worst.
Immediately after surgery, the surgeons report NRS only once
Secondary Outcomes (3)
Intraocular pressure
Intraocular pressure will be measured at two time points: before sedative medication administration and before skin incision.
Bispectral index (BIS)
Bis will be continuously recorded with BIS monitor from arrival in the operating room to discharge to ward (about 30 minutes after surgery).
Visual analogue scale (VAS)
VAS will be recorded at the following time points until 1h postoperatively: before sedative medication administration, before skin incision, every 10 minutes intraoperatively and 1h postoperatively
Study Arms (2)
Dexmedetomidine
EXPERIMENTALDexmedetomidine will be used for perioperative sedation.
Midazolam
EXPERIMENTALMidazolam will be used for perioperative sedation.
Interventions
loading dose 0.5-2.5ug/kg followed by continuous infusion 0.2-0.5ug/kg/h
Eligibility Criteria
You may qualify if:
- Patients scheduled for ophthalmic surgery with retrobulbar nerve block
You may not qualify if:
- Patients with severe cardiac, pulmonary, hepatic, or renal dysfunction. Patients with a preoperative history of mental disorder, hearing disorder, II-III degree atrioventricular block, known allergy or hypersensitivity to a2 receptor agonists and refusal of (or contraindications to) PNB. Patients with anticipated difficult airway.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye, Ear, Nose and Throat Hospital
Shanghai, Shanghai Municipality, 200031, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wenxian Li, M.D. Ph.D.
Eye and ENT Hospital of Fudan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Anesthesiologist
Study Record Dates
First Submitted
July 9, 2019
First Posted
July 12, 2019
Study Start
November 1, 2019
Primary Completion
July 31, 2021
Study Completion
December 31, 2021
Last Updated
November 3, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share